(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

H.F.M BY TICEBA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

H.F.M BY TICEBA

ST13

US500000079314148

Classe

1, 5, 42, 44

Pedido

79314148

Registro

6959288

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

37

Atualização mais recente

23/05/2023

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

1, 5, 42, 44

Data de depósito

10/04/2021

Data de registro

24/01/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

24/01/2023

Última transação

24/01/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

01

Localização do titular

DE

Examinador

BLANE, SUZANNE

Unidade examinadora

M50

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of the wording "H.F.M.", underlined and above the wording "BY TICEBA", all in the color blue. The wording is surrounded by 8 rods having a small ball at each end and alternating in color, with every other one in the color blue and the others in the color green. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.

Titulares e representantes

Titulares

D. G. (pessoa física)

Representantes

Sean K. Owens WOOD HERRON & EVANS LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Stem cells for scientific or research use; cell growth media for growing cells for scientific use

Classe 5

Pharmaceutical drugspharmaceutical drugs for treatment of skin diseasesantibioticsimmune suppressantsanti-inflammatory pharmaceuticals; Pharmaceutical drugs for treatment of disease and disorders of the respiratory systemthe gastrointestinal systemthe endocrine systemthe cardiovascular systemthe nervous systemthe musculoskeletal systemthe urinary systemthe integumentary systemthe reproductive systemfor the treatment of blood diseases and disorders; Pharmaceutical and veterinary preparations for treatment of vertigomigrainenauseavomitingfor treatment of skin diseaseswound healing; Pharmaceutical preparations for anti-aging; Diagnostic agents for medical use; Preparations for medical purposesfor the treatment of skin diseases; Substances for medical usefor regeneration of tissue and anti-inflammation; Stem cells for medical purposes; Stem cells for veterinary purposes; Stem cells for aesthetic purposesfor anti-agingfor use in dermatology procedures; Somatic stem cell therapeuticsfor medical therapeutic use; Fibroblasts for medical use; Fibroblasts for aesthetic purposesfor use in dermatology procedures; Pharmaceutical implantsimplantable surgery bonesbone graftscellsbone marrow; Surgical implants derived from stem cellssurgical implants derived from living tissues and living stem cells; Surgical implants derived from fibroblastssurgical implants comprised of living fibroblasts tissue cells; Biological tissue for implantationimplants comprising living tissues; Cell growth media for growing cells for medical use; Pharmaceutical preparations for tissue regeneration; Vascular grafts; Living tissuesurgical implants comprised of living tissues; Biotechnologically engineered tissue productscell sheets/plasters for wound healing/burnseye lense graftsbone graftsbiological tissue graftshuman allograft tissue

Classe 42

Stem cell research; scientific research and development and medical research and development in the field of stem cells; Scientific researchtesting and analysis services in the field of regenerative medicine and tissue engineering; Scientific research for medical purposes; Medical research; Research and development of new products for others; Consultancy in the field of pharmaceutical research; Providing information on medical and scientific research on pharmaceutical products; Biomedical research; Preparation of reports relating to scientific researchtechnical writing for others; Research in the field of biotechnology; Research in the field of gene therapy; Research and development in the field of immunology; Research and development in the field of antibodies; Research and development in the field of antibody technology; Research and development in the field of bacteriology; Research and development in the field of gene expression systems; Research and development in the field of vaccines; Research and development services for the pharmaceutical industry; Research and development services in the field of biotechnology; Development of industrial processesengineering of industrial processes to manufacture stem cells; Development of industrial processesin the field of regenerative medicine and tissue engineering;Industrial process research in the field of regenerative medicinetissue engineeringchemical engineering

Classe 44

Medical services relating to the removaltreatmentprocessing and preservation of medical cells and human tissuestem cells and bone marrowalso in the field of regenerative medicineincluding tissue engineering; medical services in connection with the removaltreatment and processing of human tissue and stem cellshuman tissue and stem cell bank servicesincluding in the field of regenerative medicineincluding tissue engineering; medical services relating to the cultivation and extraction of stem cells; medical services in connection with the cultivation and extraction of stem cells

Publicações

Histórico de despachos e eventos da marca no USPTO.

37 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

23/05/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/05/2023

FIMP

FINAL DISPOSITION PROCESSED

01/05/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

24/04/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

24/01/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

24/01/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

20/12/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

30/11/2022

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

30/11/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/11/2022

PUBO

PUBLISHED FOR OPPOSITION

08/11/2022

GPNX

NOTIFICATION PROCESSED BY IB

07/11/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

19/10/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

19/10/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

19/10/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

29/09/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

29/09/2022

GNRT

NON-FINAL ACTION E-MAILED

29/09/2022

CNRT

NON-FINAL ACTION WRITTEN

29/09/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/08/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/08/2022

ALIE

ASSIGNED TO LIE

09/08/2022

NREV

NOTICE OF REVIVAL - E-MAILED

13/07/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

13/07/2022

PETG

PETITION TO REVIVE-GRANTED

13/07/2022

PROA

TEAS PETITION TO REVIVE RECEIVED

13/07/2022

MAB2

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND

13/07/2022

ABN2

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE

13/07/2022

RFNT

REFUSAL PROCESSED BY IB

15/01/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

28/12/2021

RFRR

REFUSAL PROCESSED BY MPU

28/12/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/12/2021

CNRT

NON-FINAL ACTION WRITTEN

01/12/2021

DOCK

ASSIGNED TO EXAMINER

30/11/2021

MAFR

APPLICATION FILING RECEIPT MAILED

02/07/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

28/06/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

25/06/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace H.F.M BY TICEBA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.